0 followers
Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. Their lead program, OP-1250, a potential best-in-class complete estrogen receptor antagonist (CERAN), is in development to treat estrogen receptor-positive (ER+), human epidermal growth factor... Read more
Sean P. Bohen
SpringWorks Therapeutics
6 followers
Biofourmis
6 followers
C4 Therapeutics
5 followers
Summit Therapeutics
5 followers
Tectonic Therapeutic
4 followers
Dyne Therapeutics
3 followers
Fortis Life Sciences
1 follower
Scholar Rock
1 follower
Janux Therapeutics
1 follower
Aspen Neuroscience
1 follower
Bolt Threads
1 follower
Explore companies